As European markets experience a lift, with the STOXX Europe 600 Index climbing 0.90% amid easing inflation and supportive monetary policy from the European Central Bank, investors are increasingly ...

BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioGaia's total investment in IBT thus amounts to approximately SEK 82 million and its holding to 94.5 per cent. Efforts to evaluate the possibility for a separate listing of IBT are continuing.

EQT Public Value to invest in BioGaia through participation in a directed issue As an active and long-term owner, EQT Public Value intends to work closely with existing shareholders, the board of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In light of these benefits and no signs of toxicity, early initiation of BioGaia ProTectis is a standard of practice in our neonatal intensive care unit which has continued to prevent NEC in our ...

We're going to check out a few of the best picks from our screener tool. Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization ...

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: BioGaia (STO:BIOG-B) has previously owned 50 per cent of TwoPac AB and the remaining shares have been held by TwoPac’s management.

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops ...

In Australia, BioGaia has begun rolling out its first global brand campaign to promote its BioGaia Protectis baby Probiotic ...